BDBM50217355 (E)-4-(6-amino-5-((2-(methylsulfonamido)ethoxyimino)methyl)pyrimidin-4-yl)-N-(4-(pyrrolidin-1-yl)phenyl)piperazine-1-carboxamide::CHEMBL237338

SMILES CS(=O)(=O)NCCO\N=C\c1c(N)ncnc1N1CCN(CC1)C(=O)Nc1ccc(cc1)N1CCCC1

InChI Key InChIKey=ZQEIHNPUVQXSCX-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50217355   

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50217355((E)-4-(6-amino-5-((2-(methylsulfonamido)ethoxyimin...)
Affinity DataIC50: 150nMAssay Description:Inhibition of human FLT3More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed